1. Home
  2. DAWN vs DRH Comparison

DAWN vs DRH Comparison

Compare DAWN & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

HOLD

Current Price

$9.33

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAWN
DRH
Founded
2018
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DAWN
DRH
Price
$21.42
$9.33
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$26.00
$10.08
AVG Volume (30 Days)
6.4M
1.8M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
3.75%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$158,182,000.00
N/A
Revenue This Year
$55.03
$2.99
Revenue Next Year
$28.12
$2.08
P/E Ratio
N/A
$38.41
Revenue Growth
20.60
N/A
52 Week Low
$5.64
$6.19
52 Week High
$21.46
$10.67

Technical Indicators

Market Signals
Indicator
DAWN
DRH
Relative Strength Index (RSI) 81.44 42.91
Support Level $10.30 $9.07
Resistance Level N/A $9.37
Average True Range (ATR) 0.07 0.23
MACD -0.16 -0.01
Stochastic Oscillator 79.55 20.34

Price Performance

Historical Comparison
DAWN
DRH

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.

Share on Social Networks: